Completed PHASE4 INTERVENTIONAL 2-arm NCT00839358

Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation (MACHT)

Midodrine and Albumin for Cirrhotic Patients in the Waiting List for Liver Transplantation

Sponsor: Hospital Clinic of Barcelona

Conditions Gastrointestinal Bleeding Hepatic Encephalopathy Hyponatremia Renal Failure Sepsis

Updated 5 times since 2017 Last updated: Aug 17, 2016 Started: Aug 31, 2008 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Gastrointestinal Bleeding and Hepatic Encephalopathy and is currently completed. Hospital Clinic of Barcelona leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Clinic of Barcelona
Hospital Universitari de Bellvitge
Maternal-Infantil Vall d´Hebron Hospital

Data source: Hospital Clinic of Barcelona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Villarroel 170, Spain